Cited by 50Metabolism and Genetic DisordersAmino Acid Enzymes and MetabolismGlycogen Storage Diseases and Myoclonus

Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I

St-Louis, M., Leclerc, B., Laine, J., K.Salo, M., Holmberg, C., Tanguay, R. M.·1994·Human Molecular Genetics

Abstract

Hereditary tyrosinemia type I is a metabolic disease caused by a deficiency of fumarylacetoacetate hydrolase (FAH, EC 3.7.1.2), the last enzyme in the catabolic pathway of tyrosine. The molecular basis of FAH deficiency was examined in five Finnish patients suffering from this severe metabolic disease. No immunoreactive FAH nor enzymatic activity were found in their liver. Direct sequencing of the 14 exons of the FAH gene showed a G to A transition, which predicts a change from tryptophan to a stop codon (TGG-->TGA) at position 262 (W262X). Four of the five patients examined were homozygous for the mutation. Allele specific oligonucleotide hybridization showed a predominance of the W262X mutation in Finland (9 of 10 alleles) and the absence of this mutant allele in patients from other parts of the world. The loss of a BsaJI restriction site in those patients may be used for diagnosis.

Integrity signals

Registry

Crossref · 10.1093/hmg/3.1.69

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
St-Louis, M., Leclerc, B., Laine, J., K.Salo, M., Holmberg, C., & Tanguay, R. M.
Affiliations
University of Helsinki (FI)
Corresponding author
Tanguay, R. M.
Venue
Human Molecular Genetics
Published
1994-01-01
Volume
3
Issue
1
Pages
69-72
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2018412856
Cited by
50
References
0
Citations by year
2024: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 2 · 2014: 1 · 2013: 1 · 2012: 1
FWCI
4.23
Type
journal article
Language
en
Open access
closed
Locations
  • Human Molecular Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
Keywords
tyrosinemia type I, fumarylacetoacetate hydrolase deficiency, stop codon mutation, Finnish patients, homozygous mutation, allele-specific oligonucleotide hybridization, tyrosine catabolism, molecular diagnosis
MeSH terms
Amino Acid Metabolism, Inborn Errors, Amino Acid Sequence, Base Sequence, Child, Preschool, Exons, Finland, Humans, Hydrolases, Infant, Liver, Molecular Sequence Data, Tyrosine, Polymerase Chain Reaction, Point Mutation, DNA Primers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review